2026-08-29T14:05:13Zhttps://repisalud.isciii.es/rest/oai/requestoai:repisalud.isciii.es:20.500.12105/227912024-11-28T17:21:34Zcom_20.500.12105_15322com_20.500.12105_2051col_20.500.12105_16960col_20.500.12105_16967
Repisalud
author
Gomez-Marcos, Manuel A
author
Gomez-Sanchez, Leticia
author
Patino-Alonso, Maria C
author
Recio-Rodriguez, Jose I
author
Gomez-Sanchez, Marta
author
Reigada Mendez, Rebeca
author
Marti, Ruth
author
Agudo-Conde, Cristina
author
Maderuelo-Fernandez, Jose A
author
Ramos-Asensio, Rafael
author
Garcia-Ortiz, Luis
author
Rodriguez-Sanchez, Emiliano
2024-09-10T13:09:54Z
2024-09-10T13:09:54Z
2019-01-25
Gomez-Marcos MA, Gomez-Sanchez L, Patino-Alonso MC, Recio-Rodriguez JI, Gomez-Sanchez M, Rigo Carratala F, et al. Capacity adiposity indices to identify metabolic syndrome in subjects with intermediate cardiovascular risk (MARK study). PLoS One. 2019 Jan 25;14(1):e0209992.
10.1371/journal.pone.0209992
1932-6203
PloS One
http://hdl.handle.net/20.500.13003/8898
30682054
L626070646
2-s2.0-85060542966
https://hdl.handle.net/20.500.12105/22791
457037500020
Background Obesity increases mortality, and is linked to cardiovascular diseases and metabolic syndrome (MetS). Therefore, the purpose of this study was to analyze the ability of different adiposity indices to identify subjects with MetS among people with intermediate cariovascular risk. Materials and methods The cross-sectional study involved 2478 subjects, recruited by the MARK study. Adiposity measures: general adiposity by body mass index (BMI), central adiposity by waist-to-height ratio (WHtR), fat mass percent by the Clinica Universidad de Navarra-body adiposity estimator (CUN-BAE), percentage of body fat and of visceral adipose tissue by body roundness index (BRI) and visceral obesity and general adiposity with body shape index (ABSI). The diagnosis of MetS was made in accordance with the criteria established in the international consensus of the Joint Scientific Statement National Cholesterol Education Program III. Results The highest correlation coefficients were obtained by the glycemic components (HbA1c and FPG) of the MetS and ranged from 0.155 to 0.320. The exception was ABSI, which showed lower values in the global analysis and in the males. Values of the area under the ROC curve with the adiposity indices ranged from 0.773 with the BMI in males to 0.567 with ABSI in males. In the logistic regression analysis, all adiposity factors, except ABSI, showed similar OR values of MetS after adjusting for possible confounding factors. In the global analysis, the adiposity index that showed a highest OR of MetS was CUN-BAE (OR 5.50; 95% CI 4.27-7.09). In the analysis by gender, the highest ORs were BMI in males (OR 5.98; 95% CI 4.70-7.60) and both WHtR and BRI in females (OR 4.15; 95% CI 3.09-5.58). Conclusion All adiposity indices, except for ABSI, show an association with MetS and similar ability to detect subjects with MetS among people with intermediate cariovascular risk.
eng
Capacity adiposity indices to identify metabolic syndrome in subjects with intermediate cardiovascular risk (MARK study)
research article